abstract |
The present invention finds a protein that is expressed in various types of cells and functions as a herpesvirus receptor, and prevents the entry of the virus into the cell by inhibiting the binding between the receptor and the herpesvirus. It aims at providing the preventive agent or therapeutic agent of an infectious disease. The present invention provides a pharmaceutical composition for preventing or treating herpes virus infection, comprising as an active ingredient a substance that inhibits the binding between glycoprotein B and non-muscle myosin heavy chain IIA or non-muscle myosin heavy chain It is. |